Avalo Therapeutics AVTX Maryland — Annual base rent
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept avtx:LesseeOperatingLeaseLiabilityAnnualBaseRent.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's maryland — annual base rent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Avalo Therapeutics's maryland — annual base rent?
- Avalo Therapeutics (AVTX) reported maryland — annual base rent of $200K in Q1 2026.
- How has Avalo Therapeutics's maryland — annual base rent changed year-over-year?
- Avalo Therapeutics's maryland — annual base rent decreased by 0.0% year-over-year, from $200K to $200K.
- What is the long-term trend for Avalo Therapeutics's maryland — annual base rent?
- Over 4 years (2021 to 2025), Avalo Therapeutics's maryland — annual base rent has grown at a 2.6% compound annual growth rate (CAGR), from $723.34K to $800K.
- What does maryland — annual base rent mean?
- The fixed annual recurring cash payment obligation for operating leases related to the Maryland geographic segment. This represents the baseline facility occupancy cost and is a key component of the company's fixed operating expenses.